Loading…
Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis
Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for develo...
Saved in:
Published in: | Current neuropharmacology 2023-01, Vol.21 (6), p.1319-1328 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3 |
container_end_page | 1328 |
container_issue | 6 |
container_start_page | 1319 |
container_title | Current neuropharmacology |
container_volume | 21 |
creator | Ilzarbe, Lidia Ilzarbe, Daniel Gutiérrez-Arango, Felipe Baeza, Inmaculada |
description | Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents.
Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex.
Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex.
Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant.
Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics. |
doi_str_mv | 10.2174/1570159X21666221027143920 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2730319906</sourcerecordid><originalsourceid>FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3</originalsourceid><addsrcrecordid>eNp1Uk2v0zAQjBCI93jwF1C4cQnYTuzEXFBVPqUiEAWJm-U4m8bg2MF2Wnrhxv_GeX1UcODktWZmd1azWfYIoycE19VTTGuEKf9CMGOMEIxIjauSE3Qru8RNTQuGObqd6sQrFuJFdi-ErwgR2pD6bnZRshJRXDaX2c8t_Mhf6L4HD1ZByLXNt-DnMf_gnZEqpv8G9mCukfWgTZeIubRdvuqcgaDAxpA7m69s1FM4qsFFrcKzfJVvjyHCKNM3_wh7DYdr2TuIslhZaY5Bh_vZnV6aAA9u3qvs86uXn9Zvis3712_Xq03RVryKRdMS2vNKVrKlXGFJa8wJa1GdUNWykmCsFFSMKk4p7jDnnNVNw3tVow5YX15lz099p7kdoVtMe2nE5PUo_VE4qcW_iNWD2Lm9wKgkVUl46vD4poN332cIUYw6LW-MtODmIEhdojINRixR-YmqvAvBQ3-eg5FYAhT_DTBpH_5t9Kz8k1gi_DoR2uR0kGNQegnuTBxinMThcBAwe_gmAxhQUSg3CjeBnb1JtY1JK6ZhEjuwHoT0KSMDQodgxXJAYjkgsXdmHiE5XoAZBBNhkjsQOO1Z_gYKNsuR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2730319906</pqid></control><display><type>article</type><title>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</title><source>PubMed Central</source><creator>Ilzarbe, Lidia ; Ilzarbe, Daniel ; Gutiérrez-Arango, Felipe ; Baeza, Inmaculada</creator><creatorcontrib>Ilzarbe, Lidia ; Ilzarbe, Daniel ; Gutiérrez-Arango, Felipe ; Baeza, Inmaculada</creatorcontrib><description>Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents.
Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex.
Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex.
Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant.
Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.</description><identifier>ISSN: 1570-159X</identifier><identifier>EISSN: 1875-6190</identifier><identifier>DOI: 10.2174/1570159X21666221027143920</identifier><identifier>PMID: 36305138</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers</publisher><subject>Adolescent ; Adult ; Antipsychotic Agents - therapeutic use ; Child ; Female ; Humans ; Male ; Medicine, Neurology, Pharmacology, Neuroscience ; Olanzapine ; Prolactin ; Risperidone - therapeutic use ; Sex Characteristics</subject><ispartof>Current neuropharmacology, 2023-01, Vol.21 (6), p.1319-1328</ispartof><rights>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</rights><rights>2023 Bentham Science Publishers 2023 Bentham Science Publishers</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324329/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324329/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36305138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ilzarbe, Lidia</creatorcontrib><creatorcontrib>Ilzarbe, Daniel</creatorcontrib><creatorcontrib>Gutiérrez-Arango, Felipe</creatorcontrib><creatorcontrib>Baeza, Inmaculada</creatorcontrib><title>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</title><title>Current neuropharmacology</title><addtitle>CN</addtitle><description>Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents.
Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex.
Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex.
Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant.
Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Child</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine, Neurology, Pharmacology, Neuroscience</subject><subject>Olanzapine</subject><subject>Prolactin</subject><subject>Risperidone - therapeutic use</subject><subject>Sex Characteristics</subject><issn>1570-159X</issn><issn>1875-6190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1Uk2v0zAQjBCI93jwF1C4cQnYTuzEXFBVPqUiEAWJm-U4m8bg2MF2Wnrhxv_GeX1UcODktWZmd1azWfYIoycE19VTTGuEKf9CMGOMEIxIjauSE3Qru8RNTQuGObqd6sQrFuJFdi-ErwgR2pD6bnZRshJRXDaX2c8t_Mhf6L4HD1ZByLXNt-DnMf_gnZEqpv8G9mCukfWgTZeIubRdvuqcgaDAxpA7m69s1FM4qsFFrcKzfJVvjyHCKNM3_wh7DYdr2TuIslhZaY5Bh_vZnV6aAA9u3qvs86uXn9Zvis3712_Xq03RVryKRdMS2vNKVrKlXGFJa8wJa1GdUNWykmCsFFSMKk4p7jDnnNVNw3tVow5YX15lz099p7kdoVtMe2nE5PUo_VE4qcW_iNWD2Lm9wKgkVUl46vD4poN332cIUYw6LW-MtODmIEhdojINRixR-YmqvAvBQ3-eg5FYAhT_DTBpH_5t9Kz8k1gi_DoR2uR0kGNQegnuTBxinMThcBAwe_gmAxhQUSg3CjeBnb1JtY1JK6ZhEjuwHoT0KSMDQodgxXJAYjkgsXdmHiE5XoAZBBNhkjsQOO1Z_gYKNsuR</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Ilzarbe, Lidia</creator><creator>Ilzarbe, Daniel</creator><creator>Gutiérrez-Arango, Felipe</creator><creator>Baeza, Inmaculada</creator><general>Bentham Science Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230101</creationdate><title>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</title><author>Ilzarbe, Lidia ; Ilzarbe, Daniel ; Gutiérrez-Arango, Felipe ; Baeza, Inmaculada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Child</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine, Neurology, Pharmacology, Neuroscience</topic><topic>Olanzapine</topic><topic>Prolactin</topic><topic>Risperidone - therapeutic use</topic><topic>Sex Characteristics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ilzarbe, Lidia</creatorcontrib><creatorcontrib>Ilzarbe, Daniel</creatorcontrib><creatorcontrib>Gutiérrez-Arango, Felipe</creatorcontrib><creatorcontrib>Baeza, Inmaculada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ilzarbe, Lidia</au><au>Ilzarbe, Daniel</au><au>Gutiérrez-Arango, Felipe</au><au>Baeza, Inmaculada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</atitle><jtitle>Current neuropharmacology</jtitle><addtitle>CN</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>21</volume><issue>6</issue><spage>1319</spage><epage>1328</epage><pages>1319-1328</pages><issn>1570-159X</issn><eissn>1875-6190</eissn><abstract>Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents.
Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex.
Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex.
Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant.
Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers</pub><pmid>36305138</pmid><doi>10.2174/1570159X21666221027143920</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1570-159X |
ispartof | Current neuropharmacology, 2023-01, Vol.21 (6), p.1319-1328 |
issn | 1570-159X 1875-6190 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324329 |
source | PubMed Central |
subjects | Adolescent Adult Antipsychotic Agents - therapeutic use Child Female Humans Male Medicine, Neurology, Pharmacology, Neuroscience Olanzapine Prolactin Risperidone - therapeutic use Sex Characteristics |
title | Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A52%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sex%20Differences%20in%20Serum%20Prolactin%20Levels%20in%20Children%20and%20Adolescents%20on%20Antipsychotics:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Current%20neuropharmacology&rft.au=Ilzarbe,%20Lidia&rft.date=2023-01-01&rft.volume=21&rft.issue=6&rft.spage=1319&rft.epage=1328&rft.pages=1319-1328&rft.issn=1570-159X&rft.eissn=1875-6190&rft_id=info:doi/10.2174/1570159X21666221027143920&rft_dat=%3Cproquest_pubme%3E2730319906%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2730319906&rft_id=info:pmid/36305138&rfr_iscdi=true |